Identification of a functional estrogen-responsive enhancer element in the promoter 2 of PRDM2 gene in breast cancer cell lines

Journal of Cellular Physiology

Volumn 227, Issue 3, 2012, Pages 964-975

  Abbondanza, Ciro ^a   De Rosa, Caterina ^a   D'Arcangelo, Andrea ^a   Pacifico, Marianna ^a   Spizuoco, Clorinda ^a   Piluso, Giulio ^a   Di Zazzo, Erika ^b   Gazzerro, Patrizia ^c   Medici, Nicola ^a   Moncharmont, Bruno ^b   Alfredo Puca, Giovanni ^a  

^a SECOND UNIVERSITY OF NAPLES   (Italy)

^b UNIVERSITY OF MOLISE   (Italy)

^c UNIVERSITY OF SALERNO   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

B LYMPHOCYTE INDUCED MATURATION PROTEIN 1; B LYMPHOCYTE INDUCED MATURATION PROTEIN 2; DNA TOPOISOMERASE (ATP HYDROLYSING); ESTROGEN; ESTROGEN RECEPTOR ALPHA; HISTONE H3; HISTONE H4; TOPOISOMERASE IIBETA; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG;

ARTICLE; BREAST CANCER; CANCER CELL CULTURE; CONTROLLED STUDY; ESTROGEN RESPONSIVE ELEMENT; GENE EXPRESSION; GENE IDENTIFICATION; HISTONE ACETYLATION; HISTONE METHYLATION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN BINDING; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TRANSCRIPTION INITIATION; WESTERN BLOTTING;

ANIMALS; BASE SEQUENCE; BREAST NEOPLASMS; CELL DIFFERENTIATION; CELL LINE, TUMOR; CELL SURVIVAL; CERCOPITHECUS AETHIOPS; COS CELLS; DNA-BINDING PROTEINS; ENHANCER ELEMENTS, GENETIC; ESTRADIOL; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HISTONE-LYSINE N-METHYLTRANSFERASE; HUMANS; MOLECULAR SEQUENCE DATA; NUCLEAR PROTEINS; PROMOTER REGIONS, GENETIC; TRANSCRIPTION FACTORS;

EID: 84155178044     PISSN: 00219541     EISSN: 10974652     Source Type: Journal    
DOI: 10.1002/jcp.22803     Document Type: Article

References (56)

1. Abbondanza C, de Nigris F, De Rosa C, Rossiello R, Puca GA, Napoli C. 2008. Silencing of YY1 downregulates RIZ1 promoter in human osteosarcoma. Oncol Res 17: 33-41.
2. Abbondanza C, Medici N, Nigro V, Rossi V, Gallo L, Piluso G, Belsito A, Roscigno A, Bontempo P, Puca AA, Molinari AM, Moncharmont B, Puca GA. 2000. The retinoblastoma-interacting zinc-finger protein RIZ is a downstream effector of estrogen action. Proc Natl Acad Sci USA 97: 3130-3135.
3. Altucci L, Addeo R, Cicatiello L, Dauvois S, Parker MG, Truss M, Beato M, Sica V, Bresciani F, Weisz A. 1996. 17beta-Estradiol induces cyclin D1 gene transcription, p36D1-p34cdk4 complex activation and p105Rb phosphorylation during mitogenic stimulation of G(1)-arrested human breast cancer cells. Oncogene 12: 2315-2324.
4. Bhat-Nakshatri P, Wang G, Collins NR, Thomson MJ, Geistlinger TR, Carroll JS, Brown M, Hammond S, Srour EF, Liu Y, Nakshatri H. 2009. Estradiol-regulated microRNAs control estradiol response in breast cancer cells. Nucleic Acids Res 37: 4850-4861.
5. Carling T, Kim K-C, Yang X-H, Gu J, Zhang X-K, Huang S. 2004. A histone methyltransferase is required for maximal response to female sex hormones. Mol Cell Biol 24: 7032-7042.
6. Carroll JS, Meyer CA, Song J, Li W, Geistlinger TR, Eeckhoute J, Brodsky AS, Keeton EK, Fertuck KC, Hall GF, Wang Q, Bekiranov S, Sementchenko V, Fox EA, Silver PA, Gingeras TR, Liu XS, Brown M. 2006. Genome-wide analysis of estrogen receptor binding sites. Nat Genet 38: 1289-1297.
7. Chambery A, Farina A, Di Maro A, Rossi M, Abbondanza C, Moncharmont B, Malorni L, Cacace G, Pocsfalvi G, Malorni A, Parente A. 2006. Proteomic analysis of MCF-7 cell lines expressing the zinc-finger or the proline-rich domain of retinoblastoma-interacting-zinc-finger protein. J Proteome Res 5: 1176-1185.
8. Du Y, Carling T, Fang W, Piao Z, Sheu JC, Huang S. 2001. Hypermethylation in human cancers of the RIZ1 tumor suppressor gene, a member of a histone/protein methyltransferase superfamily. Cancer Res 61: 8094-8099.
9. Duan R, Porter W, Safe S. 1998. Estrogen-induced c-fos protooncogene expression in MCF-7 human breast cancer cells: Role of estrogen receptor Sp1 complex formation. Endocrinology 139: 1981-1990.
10. Dubik D, Shiu RP. 1992. Mechanism of estrogen activation of c-myc oncogene expression. Oncogene 7: 1587-1594.
11. Garcia-Bassets I, Kwon YS, Telese F, Prefontaine GG, Hutt KR, Cheng CS, Ju BG, Ohgi KA, Wang J, Escoubet-Lozach L, Rose DW, Glass CK, Fu XD, Rosenfeld MG. 2007. Histone methylation-dependent mechanisms impose ligand dependency for gene activation by nuclear receptors. Cell 128: 505-518.
12. Gazzerro P, Abbondanza C, D'Arcangelo A, Rossi M, Medici N, Moncharmont B, Puca GA. 2006. Modulation of RIZ gene expression is associated to estradiol control of MCF-7 breast cancer cell proliferation. Exp Cell Res 312: 340-349.
13. Gazzerro P, Bontempo P, Schiavone EM, Abbondanza C, Moncharmont B, Armetta I, Medici N, De Simone M, Nola E, Puca GA, Molinari AM. 2001. Differentiation of myeloid cell lines correlates with a selective expression of RIZ protein. Mol Med 7: 552-560.
14. Gottlicher M, Heck S, Herrlich P. 1998. Transcriptional cross-talk, the second mode of steroid hormone receptor action. J Mol Med 76: 480-489.
15. Gyory I, Fejer G, Ghosh N, Seto E, Wright KL. 2003. Identification of a functionally impaired positive regulatory domain I binding factor 1 transcription repressor in myeloma cell lines. J Immunol 170: 3125-3133.
16. He L, Yu JX, Liu L, Buyse IM, Wang MS, Yang QC, Nakagawara A, Brodeur GM, Shi YE, Huang S. 1998. RIZ1, but not the alternative RIZ2 product of the same gene, is underexpressed in breast cancer, and forced RIZ1 expression causes G2-M cell cycle arrest and/or apoptosis. Cancer Res 58: 4238-4244.
17. Hirai H. 1999. The transcription factor Evi-1. Int J Biochem Cell Biol 31: 1367-1371.
18. Huang S. 1999. The retinoblastoma protein-interacting zinc finger gene RIZ in 1p36-linked cancers. Front Biosci 4: D528-D532.
19. Hurd C, Dinda S, Khattree N, Moudgil VK. 1999. Estrogen-dependent and independent activation of the P1 promoter of the p53 gene in transiently transfected breast cancer cells. Oncogene 18: 1067-1072.
20. Ince TA, Scotto KW. 1995. A conserved downstream element defines a new class of RNA polymerase II promoters. J Biol Chem 270: 30249-30252.
21. Jiang G, Liu L, Buyse IM, Simon D, Huang S. 1999. Decreased RIZ1 expression but not RIZ2 in hepatoma and suppression of hepatoma tumorigenicity by RIZ1. Int J Cancer 83: 541-546.
22. Jiang GL, Huang S. 2000. The yin-yang of PR-domain family genes in tumorigenesis. Histol Histopathol 15: 109-117.
23. Johnson PF, McKnight SL. 1989. Eukaryotic transcriptional regulatory proteins. Annu Rev Biochem 58: 799-839.
24. Jones NC, Rigby PW, Ziff EB. 1988. Trans-acting protein factors and the regulation of eukaryotic transcription: Lessons from studies on DNA tumor viruses. Genes Dev 2: 267-281.
25. Ju B-G, Lunyak VV, Perissi V, Garcia-Bassets I, Rose DW, Glass CK, Rosenfeld MG. 2006. A topoisomerase II{beta}-mediated dsDNA break required for regulated transcription. Science 312: 1798-1802.
26. Kel AE, Gossling E, Reuter I, Cheremushkin E, Kel-Margoulis OV, Wingender E. 2003. MATCH: A tool for searching transcription factor binding sites in DNA sequences. Nucleic Acids Res 31: 3576-3579.
27. Kim KC, Geng L, Huang S. 2003. Inactivation of a histone methyltransferase by mutations in human cancers. Cancer Res 63: 7619-7623.
28. Kumar V, Green S, Stack G, Berry M, Jin JR, Chambon P. 1987. Functional domains of the human estrogen receptor. Cell 51: 941-951.
29. Laemmli UK. 1970. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227: 680-685.
30. Lal G, Padmanabha L, Smith BJ, Nicholson RM, Howe JR, O'Dorisio MS, Domann FE Jr. 2006. RIZ1 is epigenetically inactivated by promoter hypermethylation in thyroid carcinoma. Cancer 107: 2752-2759.
31. Liu L, Shao G, Steele-Perkins G, Huang S. 1997. The retinoblastoma interacting zinc finger gene RIZ produces a PR domain-lacking product through an internal promoter. J Biol Chem 272: 2984-2991.
32. Mangelsdorf DJ, Thummel C, Beato M, Herrlich P, Schütz G, Umesono K, Blumberg B, Kastner P, Mark M, Chambon P, Evans RM. 1995. The nuclear receptor superfamily: The second decade. Cell 83: 835.
33. Marmorstein R. 2003. Structure of SET domain proteins: A new twist on histone methylation. Trends Biochem Sci 28: 59-562.
34. McKenna NJ, O'Malley BW. 2002. Combinatorial control of gene expression by nuclear receptors and coregulators. Cell 108: 465.
35. Medici N, Abbondanza C, Nigro V, Rossi V, Piluso G, Belsito A, Gallo L, Roscigno A, Bontempo P, Puca AA, Molinari AM, Moncharmont B, Puca GA. 1999. Identification of a DNA binding protein cooperating with estrogen receptor as RIZ (retinoblastoma interacting zinc finger protein). Biochem Biophys Res Commun 264: 983-989.
36. Métivier R, Penot G, Hübner MR, Reid G, Brand H, Kos M, Gannon F. 2003. Estrogen receptor-[alpha] directs ordered, cyclical, and combinatorial recruitment of cofactors on a natural target promoter. Cell 115: 751.
37. Migliaccio A, Castoria G, Di Domenico M, De Falco A, Bilancio A, Auricchio F. 2002. Src is an initial target of sex steroid hormone action. Ann NY Acad Sci 963: 185-190.
38. Nigro V, Okazaki Y, Belsito A, Piluso G, Matsuda Y, Politano L, Nigro G, Ventura C, Abbondanza C, Molinari AM, Acampora D, Nishimura M, Hayashizaki Y, Puca GA. 1997. Identification of the Syrian hamster cardiomyopathy gene. Hum Mol Genet 6: 601-607.
39. Nilsson S, Makela S, Treuter E, Tujague M, Thomsen J, Andersson G, Enmark E, Pettersson K, Warner M, Gustafsson J-A. 2001. Mechanisms of estrogen action. Physiol Rev 81: 1535-1565.
40. Nishikata I, Sasaki H, Iga M, Tateno Y, Imayoshi S, Asou N, Nakamura T, Morishita K. 2003. A novel EVI1 gene family, MEL1, lacking a PR domain (MEL1S) is expressed mainly in t(1;3)(p36;q21)-positive AML and blocks G-CSF-induced myeloid differentiation. Blood 102: 3323-3332.
41. O'Lone R, Frith MC, Karlsson EK, Hansen U. 2004. Genomic targets of nuclear estrogen receptors. Mol Endocrinol 18: 1859-1875.
42. Paech K, Webb P, Kuiper GGJM, Nilsson S, Gustafsson J-A, Kushner PJ, Scanlan TS. 1997. Differential ligand activation of estrogen receptors ER{alpha} and ER at AP1 sites. Science 277: 1508-1510.
43. Pastural E, Takahashi N, Dong WF, Bainbridge M, Hull A, Pearson D, Huang S, Lowsky R, DeCoteau JF, Geyer CR. 2006. RIZ1 repression is associated with insulin-like growth factor-1 signaling activation in chronic myeloid leukemia cell lines. Oncogene 26: 1586.
44. Perillo B, Ombra MN, Bertoni A, Cuozzo C, Sacchetti S, Sasso A, Chiariotti L, Malorni A, Abbondanza C, Avvedimento EV. 2008. DNA oxidation as triggered by H3K9me2 demethylation drives estrogen-induced gene expression. Science 319: 202-2206.
45. Piao Z, Fang W, Malkhosyan S, Kim H, Horii A, Perucho M, Huang S. 2000. Frequent frameshift mutations of RIZ in sporadic gastrointestinal and endometrial carcinomas with microsatellite instability. Cancer Res 60: 4701-4704.
46. Rosenfeld MG, Glass CK. 2001. Coregulator codes of transcriptional regulation by nuclear receptors. J Biol Chem 276: 36865-36868.
47. Rossi M, Abbondanza C, D'Arcangelo A, Gazzerro P, Medici N, Moncharmont B, Puca GA. 2004. The Zn-finger domain of RIZ protein promotes MCF-7 cell proliferation. Cancer Lett 215: 229-237.
48. Rossi V, Staibano S, Abbondanza C, Pasquali D, De Rosa C, Mascolo M, Bellastella G, Visconti D, De Bellis A, Moncharmont B, De Rosa G, Puca GA, Bellastella A, Sinisi AA. 2009. Expression of RIZ1 protein (Retinoblastoma-interacting zinc-finger protein 1) in prostate cancer epithelial cells changes with cancer grade progression and is modulated in vitro by DHT and E2. J Cell Physiol 221: 771-777.
49. Sakurada KT, Kato Y, Kayama T, Huang S, Horii A. 2001. RIZ, the retinoblastoma protein interacting zinc finger gene, is mutated in genetically unstable cancers of the pancreas, stomach, and colorectum. Genes Chromosome Cancer 30: 207-211.
50. Shang Y, Hu X, DiRenzo J, Lazar MA, Brown M. 2000. Cofactor dynamics and sufficiency in estrogen receptor-regulated transcription. Cell 103: 843-852.
51. Shing DC, Trubia M, Marchesi F, Radaelli E, Belloni E, Tapinassi C, Scanziani E, Mecucci C, Crescenzi B, Lahortiga I, Odero MD, Zardo G, Gruszka A, Minucci S, Di Fiore PP, Pelicci PG. 2007. Overexpression of sPRDM16 coupled with loss of p53 induces myeloid leukemias in mice. J Clin Invest 117: 3696-3707.
52. Steele-Perkins G, Fang W, Yang XH, Van Gele M, Carling T, Gu J, Buyse IM, Fletcher JA, Liu J, Bronson R, Chadwick RB, de la Chapelle A, Zhang X, Speleman F, Huang S. 2001. Tumor formation and inactivation of RIZ1, an Rb-binding member of a nuclear protein-methyltransferase superfamily. Genes Dev 15: 2250-2262.
53. Tora L, Mullick A, Metzger D, Ponglikitmongkol M, Park I, Chambon P. 1989. The cloned human oestrogen receptor contains a mutation which alters its hormone binding properties. Embo J 8: 1981-1986.
54. Towbin H, Staehelin T, Gordon J. 1979. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: Procedure and some applications. Proc Natl Acad Sci USA 76: 4350-4354.
55. Tsai MJ, O'Malley BW. 1994. Molecular mechanisms of action of steroid/thyroid receptor superfamily members. Annu Rev Biochem 63: 451-486.
56. Ylikomi T, Bocquel MT, Berry M, Gronemeyer H, Chambon P. 1992. Cooperation of proto-signals for nuclear accumulation of estrogen and progesterone receptors. Embo J 11: 3681-3694.